Is Naproxen a Good Option for Migraines?

Naproxen is a legitimate migraine treatment backed by solid evidence, but it sits in the middle of the pack rather than at the top. A large Cochrane review found that roughly 17% of people who took naproxen were completely pain-free at two hours, compared to 8% on placebo, and about 45% got meaningful headache relief versus 29% on placebo. Those numbers beat doing nothing, yet they trail what you can get from ibuprofen, aspirin at higher doses, or triptans. Where naproxen really earns its place is in combination therapy and in specific situations like menstrual migraine prevention, where its long duration of action becomes an advantage.

What the Clinical Trials Actually Show

The best summary of naproxen’s performance as a standalone migraine drug comes from a Cochrane systematic review that pooled data from multiple randomized trials. At the standard 500 mg dose, about 1 in 6 people taking naproxen were completely pain-free at two hours, and close to half experienced at least partial headache relief. When the review looked at sustained results over 24 hours, the numbers dropped: only about 12% stayed pain-free through the full day, versus roughly 7% on placebo. Around 30% maintained headache relief over 24 hours compared to 18% on placebo.¹

A separate meta-analysis looking specifically at naproxen sodium confirmed the direction of these findings, showing the drug was significantly better than placebo for reducing pain intensity, achieving pain-free status at two hours, providing relief at four hours, and easing associated symptoms like nausea and sensitivity to light.² So the drug clearly works. The question is how it stacks up against what else is available.

How Naproxen Compares to Other Common Options

This is where naproxen’s reputation takes a hit. The Cochrane reviewers compared naproxen’s performance against other painkillers using the same methodology across different reviews, which gives an unusually clean comparison. For the outcome most migraine sufferers care about, being completely pain-free at two hours, naproxen needed to treat about 11 people for one to achieve that result. Ibuprofen 400 mg needed to treat only about 7, aspirin 1000 mg about 8, and oral sumatriptan 50 mg about 6. Even acetaminophen (paracetamol) 1000 mg came in at about 12, which is only slightly worse. For the less demanding outcome of partial headache relief at two hours, the gap widened further: ibuprofen needed to treat roughly 3 people for one success, while naproxen needed about 6.³

On paper, this makes naproxen look like a poor choice. If ibuprofen is cheaper, easier to find, and roughly twice as effective for headache relief, why would anyone pick naproxen? The answer involves several factors that clinical trials, measured at fixed time points, can miss.

Why Patients Often Prefer Naproxen Anyway

Here is where things get interesting. Despite those clinical trial numbers favoring ibuprofen, real-world patient surveys tell a different story. A cross-sectional analysis from the German Migraine and Headache Society’s headache registry found that among non-opioid painkillers, naproxen was rated the most effective by patients, with about 62% giving it a “very good” or “good” rating. That was significantly higher than ibuprofen, aspirin, or acetaminophen.⁴

Why the disconnect? A few possible explanations. First, naproxen has a longer half-life than ibuprofen, meaning it stays active in your system for more hours. Migraine attacks often last anywhere from 4 to 72 hours, and a drug that keeps working longer may prevent the headache from creeping back after the first dose wears off. Second, the patients in the registry who were using naproxen may have already tried and failed ibuprofen, meaning they self-selected into naproxen because it worked better for them personally. Third, real-world use involves repeat dosing over the course of an attack, not the single-dose snapshot that clinical trials measure. Naproxen’s longer action may give it an edge over multiple hours that a two-hour endpoint does not capture.

The Combination That Changes the Equation

If naproxen alone is a middling migraine treatment, naproxen paired with sumatriptan is a genuinely strong one. The American Headache Society lists the sumatriptan-naproxen combination as a Level A treatment (the highest evidence grade) for acute migraine in adults.⁵

A randomized trial tested sumatriptan 50 mg plus naproxen sodium 500 mg against each drug alone and against placebo. At two hours, 65% of people taking the combination had headache relief, compared to 49% with sumatriptan alone, 46% with naproxen alone, and 27% with placebo. For the tougher measure of sustained 24-hour pain relief, the combination hit 46%, versus 29% for sumatriptan, 25% for naproxen, and 17% for placebo.⁶ The combination was not just a marginal improvement; it was substantially better than either drug on its own.

The fixed-dose combination tablet (sold as Treximet in the US) was generally well tolerated in clinical trials, with no more than about 22% of adults reporting any treatment-related side effects.⁷

Naproxen’s Role in Preventing Migraine Recurrence

One of the most frustrating things about triptan-treated migraines is that the headache often comes back within 24 hours after the triptan wears off. Naproxen appears to help with this problem specifically. A study of patients who experienced frequent migraine recurrence after sumatriptan found that adding naproxen sodium 550 mg to sumatriptan 100 mg cut the recurrence rate from about 59% down to roughly 26%.⁸

This makes pharmacological sense. Sumatriptan works fast but clears the body within hours. Naproxen lingers much longer, providing a kind of anti-inflammatory backstop that keeps the migraine from reasserting itself after the triptan’s effects fade. If you have been prescribed a triptan and find your migraines frequently bounce back later in the day, asking your doctor about adding naproxen is a reasonable conversation to have.

Timing Makes a Bigger Difference Than Most People Realize

One consistent finding across migraine research is that early treatment improves outcomes regardless of which drug you use, and naproxen is no exception. A study comparing naproxen sodium to an ergotamine compound found that when naproxen was taken within two hours of migraine onset, it was significantly more effective at reducing headache severity, nausea, and lightheadedness.⁹

This is worth emphasizing because many people wait to take a painkiller until the headache is severe, hoping it will go away on its own. With migraine, that delay often means the pain signals have become centrally sensitized, making them much harder to interrupt. The advice applies across the board, but it especially matters for a moderate-strength drug like naproxen: its ceiling is lower than a triptan’s, so you want every advantage, and early dosing is the single biggest one available.

A Standout Use in Menstrual Migraine

Naproxen has a specific niche in menstrual migraine prevention that other acute treatments do not fill as naturally. Menstrual migraines are attacks that cluster around the start of a period, and because their timing is somewhat predictable, short-term preventive treatment can work well.

A double-blind, placebo-controlled study of 40 women with menstrual migraine found that naproxen sodium 550 mg taken twice daily significantly reduced headache intensity, duration, the number of headache days, and the need for additional painkillers compared to placebo. The drug also helped with premenstrual pain and was well tolerated.¹⁰

A separate study examined the biological mechanism behind this effect. In 20 women with pure menstrual migraine, daily naproxen sodium starting a week before menstruation reduced prostaglandin and thromboxane levels, which are inflammatory mediators thought to play a role in triggering menstrual migraines. The number of attacks dropped from an average of about 1.7 per cycle before treatment to 1.1 per cycle by the sixth month, and attack duration was nearly halved, falling from roughly 26 hours to about 13 hours.¹¹ Few other over-the-counter drugs have this kind of evidence for scheduled preventive use in a specific migraine subtype.

Naproxen for Adolescent Migraine

Treating migraine in teenagers is tricky because many drugs approved for adults have not been well studied in younger populations, and placebo response rates tend to be unusually high in adolescent migraine trials. The sumatriptan-naproxen combination has been specifically tested in this age group.

A randomized trial in adolescents found that the combination, at various dose levels, produced significantly higher two-hour pain-free rates than placebo. The highest dose (sumatriptan 85 mg plus naproxen 500 mg) achieved a 24% two-hour pain-free rate versus 10% for placebo, and a 23% sustained pain-free rate over 2 to 24 hours versus 9% for placebo. It also significantly reduced sensitivity to light and sound.¹²

A long-term follow-up study of adolescents using this combination over many months found it was generally well tolerated. The most common side effects were nausea (7%), dizziness (3%), muscle tightness (3%), and chest discomfort (3%). About 42% of treated attacks were pain-free within two hours, and patients reported improvements in quality of life over time.¹³ Those numbers may not look dramatic, but in a population where placebo responses are high and many drugs fail to separate from placebo at all, consistent real-world benefit over months is meaningful.

Medication-Overuse Headache and Bridge Therapy

If you take acute migraine medications too frequently, typically more than 10 to 15 days per month depending on the drug, you risk developing medication-overuse headache, where the very drugs meant to treat your migraines start perpetuating a cycle of chronic daily headache. Breaking that cycle usually requires withdrawing the overused medication, and that withdrawal period can be miserable.

Naproxen has a role here too. A review of treatment strategies for medication-overuse headache found that long-acting NSAIDs, including naproxen, were valuable for relieving pain during the withdrawal period in outpatient settings.¹⁴ Its longer duration of action makes it a natural fit as a bridge therapy: it can be dosed on a scheduled basis for a limited time to ease the transition without introducing the same rebound risk as a short-acting painkiller.

The irony is worth noting. Naproxen itself can contribute to medication-overuse headache if taken too frequently, just like any other acute treatment. The key is the structured, time-limited use under medical supervision during the withdrawal phase, not open-ended daily consumption.

Pregnancy and Breastfeeding Considerations

Migraine management during pregnancy and breastfeeding is a minefield because most effective migraine drugs carry either known risks or insufficient safety data. Naproxen occupies a cautious middle ground.

During pregnancy, NSAIDs including naproxen are generally considered relatively safe in the first and second trimesters for occasional use, but they are avoided in the third trimester because they can cause premature closure of the ductus arteriosus in the fetus and may reduce amniotic fluid levels. This is a class-wide concern for all NSAIDs, not specific to naproxen.

During breastfeeding, a review of migraine drug safety classified naproxen as compatible with breastfeeding, though warranting caution.¹⁵ Only small amounts pass into breast milk, and the drug’s long half-life means those small amounts are present for a sustained period, which is why monitoring is advisable. For breastfeeding mothers who need something stronger than acetaminophen, naproxen is often one of the options discussed with a prescriber.

Healthcare Costs and the Practical Case for Combination Therapy

For people who have never tried a triptan before, starting with the sumatriptan-naproxen combination rather than a standalone triptan may actually save money over time. A study of insurance claims in a managed-care population found that patients newly prescribed the fixed-dose sumatriptan-naproxen combination had lower all-cause healthcare costs than those prescribed a single-entity triptan, driven primarily by savings in medical costs rather than pharmacy costs.¹⁶ For patients switching from one triptan to another, though, no significant cost difference was found. The cost advantage appears to come from getting the treatment right earlier, reducing repeat visits and additional treatments.

Outside the combination product, plain naproxen sodium is available over the counter in most countries at very low cost. For someone with infrequent migraines who wants to avoid a prescription, or who prefers to keep a triptan in reserve for severe attacks only, using naproxen as a first-line treatment for milder episodes is a practical and inexpensive strategy. Treating mild attacks early with an NSAID and escalating to a triptan only if they worsen is a widely used step-care approach.

Who Should Think Twice About Naproxen

Naproxen shares the safety profile of other NSAIDs. People with a history of stomach ulcers, gastrointestinal bleeding, kidney disease, or uncontrolled high blood pressure should generally avoid it or use it only under close supervision. The cardiovascular risk profile of naproxen is a subject of ongoing research, but large studies have generally found it to be among the safer NSAIDs for the heart compared to some alternatives like diclofenac, which is partly why it remains so widely used.

People who take blood thinners need to be cautious, as naproxen can increase bleeding risk. Those with aspirin-sensitive asthma should avoid all NSAIDs. And anyone already taking another NSAID daily for a condition like arthritis should not stack naproxen on top for migraine without medical guidance, as doubling up increases side-effect risk without proportionally increasing benefit.

The biggest practical limitation is that naproxen simply is not strong enough for many people’s migraines. If you have tried it at the appropriate dose (500 mg naproxen or 550 mg naproxen sodium), taken early in the attack, and it consistently fails to provide adequate relief, you have not failed some test of migraine fortitude. You have learned that your migraines need a different tool, and that is useful information to bring to your doctor.